Emergency vaccination against epidemic meningitis in Ghana: Implications for the control of meningococcal disease in West Africa

Lancet

Volumn 355, Issue 9197, 2000, Pages 30-33

  Woods, Christoper W ^a   Armstrong, Gregory ^a   Sackey, Samuel O ^c   Tetteh, Christopher ^a,c   Bugri, Samuel ^c   Perkins, Bradley A ^b   Rosenstein, Nancy E ^b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c Ghana Ministry of Health   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE;

ARTICLE; CHILD; DATA ANALYSIS; EPIDEMIC; GHANA; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MENINGITIS; NEISSERIA MENINGITIDIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 0033968870     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)03366-8     Document Type: Article

References (26)

1. Lapeyssonnie L. La meningite cerebro-spinale en Afrique. Bull World Health Organ. 28 (suppl):1963;3-114.
2. Reido F.X., Plikaytis B.D., Broome C.V. Epidemiology and prevention of meningococcal disease. Pediatr Infect Dis J. 14:1995;643-657.
3. Kaplan S.L., Feigin R.D. Clinical presentations, prognostic factors and diagnosis of bacterial meningitis. Sande M.A., Smith A.L., Root R.K. Bacterial meningitis. 1985;83-94 Churchill Livingstone, New York.
4. Smith A.W., Bradley A.K., Wall R.A.et al. Sequelae of epidemic meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg. 82:1988;312-320.
5. Wahdan M.H., Rezk F., El-Akkad A.M.et al. A controlled field trial of serogroup A meningococcal polysaccharide vaccine. Bull World Health Organ. 48:1973;667-673.
6. Spiegel A., Greindl Y., Lippeveld T.et al. Effect of two vaccination strategies on the evolution of an epidemic of meningococcal meningitis in N'Djamena, 1988. Bull World Health Organ. 71:1993;311-315.
7. Bosmans E., Vimont-Vicary P., Andre F.E., Crooy P.J., Roelants P., Vandepitte J. Protective efficacy of a bivalent (A+C) meningococcal vaccine during a cerebrospinal meningitis epidemic in Rwanda. Soc Belg Med Trop. 60:1980;297-306.
8. Reingold A.L., Broome C.V., Hightower A.W.et al. Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet. ii:1985;114-118.
9. Pinner R.W., Onyango F., Perkins B.A.et al. Epidemic meningococcal disease in Nairobi, Kenya, 1989. J Infect Dis. 166:1992;359-364.
10. Varaine F., Caugant D.A., Riou J.Y.et al. Meningitis outbreaks and vaccination strategy. Trans R Soc Trop Med Hyg. 51:1997;3-7.
11. Veeken H., Ritmeijer K., Hausman B. Priority during a meningitis epidemic: vaccination or treatment? Bull World Health Organ. 76:1998;135-141.
12. Moore P.S., Plikaytis B.A., Bolan G.A.et al. Detection of meningitis epidemics in Africa: a population-based analysis. Int J Epidemiol. 21:1992;155-162.
13. Leake JAD, Kone ML, Yada AA, et al. Early detection and response to serogroup A meningococcal diseases epidemics in sub-Saharan Africa. International Conference on Emerging Infectious Diseases, Atlanta, Georgia (abstr). Centers for Communicable Diseases Control: March 8-11, 1998.
14. WHO. Control of meningococcal disease - WHO practical guidelines. Geneva: WHO, 1995.
15. Robbins J.B., Towne D.W., Gotschlich E.C., Schneerson R. "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa. Lancet. 350:1997;880-882.
16. Hassan-King M.K.A., Wall R.A., Greenwood B.M. Meningococcal carriage, meningococcal disease and vaccination. J Infect. 16:1988;55-59.
17. Blakesbrough I.S., Greenwood B.M., Whittle H.C., Bradley A.K., Gilles H.M. Failure of meningococcal vaccination to stop the transmission of meningococci in Nigerian schoolboys. Ann Trop Med Parasitol. 77:1983;175-178.
18. Greenwood B.M., Bradley A.K., Smith A.W., Wall R.A. Mortality from meningococcal disease during an epidemic in The Gambia, West Africa. Trans R Soc Trop Med Hyg. 81:1987;536-538.
19. Response to epidemic meningitis in Africa, 1997. Wkly Epidemiol Rec. 72:1997;313-318.
20. Wilkins J., Wehrle P.F. Further characterization of responses of infants and children to meningococcal A polysaccharides. Pediatrics. 94:1979;828-832.
21. Progress toward poliomyelitis eradication: African region, 1998-April 1999. MMWR Morb Mortal Wkly Rep. 48:1999;513-518.
22. Wenger J.A., Tikhomirov E., Barakamfitiye D., Bele O., Heymann D.L. Meningococcal vaccine in sub-Saharan Africa. Lancet. 350:1997;1709.
23. Kanida A.-K., Varaine F., Henkens M., Paquet C. Meningococcal vaccine in sub-Saharan Africa. Lancet. 350:1997;1708.
24. Campagne G, Garba A, Gabre P, et al. Safety and immunogenicity of three doses of a N meningitidis A/C diphtheria conjugate vaccine in infants in Niger. Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 28-October 1, 1997.
25. Twumasi P.A., Kumah S., Leach A.et al. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J Infect Dis. 171:1995;632-638.
26. Adams W.G., Deaver K.A., Cochi S.L.et al. Decline of childhood Haemophilus influenzae Type b (Hib) disease in the vaccine era. JAMA. 269:1993;221-226.